Adam co-leads McKinsey’s global Life Sciences Practice across pharmaceuticals, medtech, and healthcare private equity. He previously led McKinsey’s Social Sector Practice globally, as well as the firm’s broader societal impact work spanning public health, education, economic mobility, and philanthropy.
With his clients, he has worked extensively with pharmaceutical companies, biotechnology firms, investors, and public health leaders across many parts of the world. His work spans corporate strategy for CXOs and boards, commercial strategy and launch, and operational improvement initiatives. He has worked extensively across disease areas, including infectious diseases/vaccines, immunology, oncology, and rare disease.
Adam publishes and speaks frequently at industry events, including the keynote addresses at BIO and the World Vaccine Congress, and serving on World Health Organization expert consultations on a range of disease areas.